SEC Form D · filed September 15, 2015
Orexigen Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Thomas Cannell · La Jolla, CAExecPatrick J. Mahaffy · La Jolla, CADirectorPreston Klassen · La Jolla, CAExecEckard S. Weber · La Jolla, CADirectorLota S. Zoth · La Jolla, CADirectorPeter K. Honig · La Jolla, CADirectorMichael Narachi · La Jolla, CAExec · DirectorBrian H. Dovey · La Jolla, CADirectorDavid J. Endicott · La Jolla, CADirectorLouis C. Bock · La Jolla, CADirectorWendy L. Dixon · La Jolla, CADirectorMaryrose N. Mallari · Bloomington, MNDirectorMichael J. Gruber · Seattle, WADirectorLeonardus H.T. Van Der Ploeg · Los Altos, CADirectorErnst-Guenter Afting · Los Altos, CAExecJoseph Hagan · La Jolla, CAExecPatrick J. Mckinney · Bloomington, MNExec · DirectorRobert P. Thorbus · Bloomington, MNDirectorReinhold P. Henke · Bloomington, MNDirectorJim Eberhard · Bozeman, MTExec · DirectorDavid Breck · Bozeman, MTDirectorDavid Sigler · Bozeman, MTExec · DirectorJohn F. Warnken-Brill · SAN FRANCISCO, CADirectorBrian F. Sheth · SAN FRANCISCO, CAExec · DirectorDaniela Taplin Lundberg · Westport, CTDirectorLawson D. Devries · Raleigh, NCExecJoseph Hagan · La Jolla, CAExecWendy L. Dixon · La Jolla, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗